Please use this identifier to cite or link to this item:
Title: Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP)
Author: Dutau, Hervé
Breen, David
Bugalho, Antonio
Dalar, Levent
Daniels, Hans
Dooms, Christophe
Eberhardt, Ralf
Ek, Lars
Encheva, Milena
Febvre, Michel
Hackl, Martin
Marran, Sirje
Papai Szekely, Zsolt
Perch, Michael
Roglic, Mihovil
Rosell, Antoni, 1963-
Rozman, Ales
Shah, Pallav
Simon, Marioara
Szlubowski, Artur
Stratakos, Grigoris
Sundset, Arve
Uibu, Toomas
Von Garnier, Christophe
Zaric, Bojan
Zdraveska, Marija
Zuccatosta, Lina
Bokan, Darijo
Husain, Syed Arshad
Bilaceroglu, Semra
Gasche Soccal, Paola
Gasparini, Stefano
Herth, Felix
Munavvar, Muhammed
Keywords: Broncoscòpia
Issue Date: 1-Jan-2018
Publisher: Karger
Abstract: Background: Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using different insertion techniques and different types of stents. Objectives: This study is an international survey conducted by the European Association of Bronchology and Interventional Pulmonology (EABIP) focusing on AS practice within 26 European countries. Methods: A questionnaire was sent to all EABIP National Delegates in February 2015. National delegates were responsible for obtaining precise and objective data regarding the current AS practice in their country. The deadline for data collection was February 2016. Results: France, Germany, and the UK are the 3 leading countries in terms of number of centres performing AS. These 3 nations represent the highest ranked nations within Europe in terms of gross national income. Overall, pulmonologists perform AS exclusively in 5 countries and predominately in 12. AS is performed almost exclusively in public hospitals. AS performed under general anaesthesia is the rule for the majority of institutions, and local anaesthesia is an alternative in 9 countries. Rigid bronchoscopy techniques are predominant in 20 countries. Amongst commercially available stents, both Dumon and Ultraflex are by far the most commonly deployed. Finally, 11 countries reported that AS is an economically viable activity, while 10 claimed that it is not. Conclusion: This EABIP survey demonstrates that there is significant heterogeneity in AS practice within Europe. Therapeutic bronchoscopy training and economic issues/reimbursement for procedures are likely to be the primary reasons explaining these findings. (C) 2017 S. Karger AG, Basel
Note: Versió postprint del document publicat a:
It is part of: Respiration, 2018-01-01, Vol. 95, Issue 1, P. 44-54
Related resource:
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
DutauH.pdf354.53 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.